Increasing clinical evidence suggests that statins may help prevent cancer in certain HIV-1–infected patients. Details here.
Does the HIV epidemic represent primarily a failure of the public health system--or is it more likely a result of failure on an individual level to take steps necessary to prevent infection?
"Don't ask, don't tell" seems to apply to gay and bisexual men when it comes to discussions about HIV with their physician. Worrisome details from a new Kaiser Family Foundation survey here.
There is emergent need to improve recognition and management of COPD in HIV-infected patients. Details here.
Despite gains, the sobering reality is that HIV transmission-- primarily via sexual means--continues at an unacceptably high rate in the United States.
Now that HIV infection is largely a chronic disease, cardiovascular disease has become a leading cause of death in this patient group. Here: a look at just how common LDL-C dyslipidemia, hypertension, and coronary heart disease really are.
The flu vaccine effectively prevents influenza in pregnant women, regardless of whether they are HIV positive, according to a new study. Results offer clinicians greater assurance to vaccinate all pregnant woman.
A once daily MVC plus DRV/r regimen had an effective role in antiretroviral drug-pretreated individuals with controlled HIV infection in this trial. In an aging HIV-infected population, with increasing comorbidities, this combination could be a safer option than standard triple therapy. More here.
It now seems probable that most people with HCV infection can be cured—even if they are co-infected with HIV. But can we bear the cost?
Antiretroviral treatment does not appear to affect a woman's ability to become pregnant or to adversely affect fetal outcomes, according to this study.
Here: a quiz about treating oral candidiasis with an azole drug in an HIV-positive person.
Preexposure Prophylaxis with Tenofovir or Emtricitabine-Tenofovir Reduces Herpes Simplex Virus Type -2 Transmission
This study demonstrates an added benefit to tenofovir-based preexposure prophylaxis regimens in preventing HSV-2.
A statistically significant association exists between efavirenz for initial HIV therapy and the risk suicidality. When this drug is given as a component of an antiretroviral drug regimen, patients should be monitored carefully for the possibility of deterioration of their depression or evidence of suicidal behavior.
Optimal timing for Starting Antiretroviral Therapy in HIV-Infected Patients with Cryptococcal Meningitis
Physicians who treat patients with cryptococcal meningitis in untreated AIDS patients should be aware that early initiation of antiretroviral therapy is associated with increased mortality.
New recommendations for HIV testing in laboratories will lead to HIV diagnosis as much as 3 to 4 weeks sooner, according to the CDC.